Similar articles

• Geographic variation of secular trends of breast cancer mortality in Spain.

  Martin-Moreno J, Gorgojo-Jimenez L, Guillen-Solvas J, Damian-Moreno J, Delgado-Rodriguez M, Galvez-Vargas R. Martin-Moreno J, et al. Neoplasma. 1993;40(1):63-8. Neoplasma. 1993. PMID: 8350951
• Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.

  Hristova L, Hakama M. Hristova L, et al. Acta Oncol. 1997;36 Suppl 9:1-60. Acta Oncol. 1997. PMID: 9143316
• Trends in mortality rates in female genital organs and breast cancers in Hungary between 1979 and 2013.

  Hartai M, Nyári TA, McNally RJ. Hartai M, et al. Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:168-72. doi: 10.1016/j.ejogrb.2015.08.021. Epub 2015 Sep 18. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26412351
• The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.

  Moss SM, Nyström L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M; Euroscreen Working Group. Moss SM, et al. J Med Screen. 2012;19 Suppl 1:26-32. doi: 10.1258/jms.2012.012079. J Med Screen. 2012. PMID: 22972808 Review.
• [Characteristics of screening-detected breast cancer and trends in its therapy].

  Taguchi T, Shiba E, Takai S, Taguchi T. Taguchi T, et al. Gan To Kagaku Ryoho. 1998 Aug;25(10):1493-8. Gan To Kagaku Ryoho. 1998. PMID: 9725039 Review. Japanese.